452.040009 USD
6.11
1.37%
Last update Dec 12, 3:59 PM EST
Pre-market
Day range
444.81000
455.99991
Previous close
445.92999
Open
444.82999
Access this stock data via API
Subscribe
Vertex Pharmaceuticals Inc.
452.04
6.11
1.37%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 3.1B 3.0B 2.8B 2.9B
Cost of revenue 414.8M 407.5M 363M 423.4M
Gross profit 2.7B 2.6B 2.4B 2.5B
Operating expense
Research & development 977.7M 978.4M 979.7M 5.6B
Selling general and admin 445.1M 424.6M 396.4M 377.6M
Other operating expenses
Operating income 1.2B 1.2B 1.0B -3.5B
Non operating interest income
Income 125.7M 122.4M 120.9M 128.2M
Expense 3.3M 3.7M 3M 2.8M
Other income expense -62.4M 10.1M -418.6M 4.5B
Pretax income 1.3B 1.3B 730.4M 1.1B
Tax provision 215.9M 250.1M 84.1M 223.5M
Net income 1.1B 1.0B 646.3M 913M
Basic EPS 4.2 4.0 2.5 3.6
Diluted EPS 4.2 4.0 2.5 3.5
Basic average shares 255.6M 256.7M 256.9M 257.5M
Diluted average shares 257.6M 258.9M 259.5M 260.5M
EBITDA 1.4B 1.3B 1.2B -3.4B
Net income from continuing op. 1.1B 1.0B 646.3M 913M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 36 minutes

08:53
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).